Symptoms during cancer pain treatment following WHO-guidelines: A longitudinal follow-up study of symptom prevalence, severity and etiology

Pain

Volumn 93, Issue 3, 2001, Pages 247-257

  Meuser, Thomas ^a   Pietruck, Christian ^a   Radbruch, Lukas ^a   Stute, Petra ^a   Lehmann, Klaus A ^a   Grond, Stefan ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Adjuvants; Analgesics; Cancer pain; Opioids; Symptoms; WHO guidelines

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; CLODRONIC ACID; CLONAZEPAM; CORTICOSTEROID; DEXAMETHASONE; DIAZEPAM; DIPYRONE; ETIDRONIC ACID; FLUNITRAZEPAM; FLURBIPROFEN; HALOPERIDOL; HYPNOTIC AGENT; LACTULOSIS; LAXATIVE; METOCLOPRAMIDE; MORPHINE; NAPROXEN; NEUROLEPTIC AGENT; OPIATE AGONIST; RANITIDINE; SCOPOLAMINE BUTYL BROMIDE; TRAMADOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; ADVANCED CANCER; AGED; ANALGESIA; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CARCINOGENESIS; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DRUG EFFICACY; ERYTHEMA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PAIN ASSESSMENT; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SELF EVALUATION; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION; XEROSTOMIA;

AGED; ANALGESICS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PRACTICE GUIDELINES; PREVALENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; WORLD HEALTH ORGANIZATION;

EID: 0034882106     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(01)00324-4     Document Type: Article

References (48)

1. Fatigue and its associated factors in ambulatory cancer patients: A preliminary study
2. Hospitalized advanced cancer patients: A profile
3. Recent developments in palliative cancer care
4. The incidence of narcotic-induced emesis
5. Pain and its treatment in outpatients with metastatic cancer
6. Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of life
7. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability
8. Common symptoms in patients with advanced cancer
9. Reduction in constipation and laxative requirements following opioid rotation to methadone: A report of four cases
10. The symptoms of advanced cancer: Identification of clinical and research priorities by assessment of prevalence and severity
11. Experiences with the prescription of opioids: A patient questionnaire
12. Constipation in cancer patients: Prevalence, pathogenesis, and cost-related issues
13. Validation of WHO-Guidelines for cancer pain relief during the last days and hours of life
14. Prevalence and pattern of symptoms in patients with cancer pain - A prospective evaluation of 1635 cancer patients referred to a pain clinic
15. Assessment of cancer pain a prospective evaluation in 2266 cancer patients referred to a pain clinic
16. Assessment and treatment of neuropathic cancer pain following WHO-guidelines
17. Symptom management for patients with pancreatic cancer
18. Oncologists and primary care physicians' attitudes towards pain control and morphine prescribing in France
19. Side effects of opioids in chronic pain treatment
20. Physical and psychological needs of patients dying from colo-rectal cancer
21. Assessment of dyspnea in advanced cancer patients
22. Pain control. Barriers to use available information
23. Oral naloxone reverses opioid-associated constipation
24. Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home
25. Psychological and symptom distress in terminal cancer patients with met and unmet needs
26. Contributing factors to physical symptoms in terminally-ill cancer patients
27. Assessing the reliability of patient, nurse, and family caregiver symptom ratings in hospitalized advanced cancer patients
28. A comparison of patient and proxy symptom assessments in advanced cancer patients
29. Temporal presentation of chronic cancer pain: Transitory pains on admission to a multidisciplinary pain clinic
30. Symptom prevalence, characteristics and distress in a cancer population
31. Constipation and the use of laxatives - A comparison between transdermal fentanyl and oral morphine
32. Dyspnea in terminally ill cancer patients
33. Clinical symptoms and length of survival in patients with terminal cancer
34. Symptoms and functional status of patients with disseminated cancer visiting outpatient departments
35. Death from cancer and death from other causes: The relevance of the hospice approach
36. Fatigue in advanced cancer: A prospective controlled cross-sectional study
37. Prevalence of symptoms among patients with advanced cancer: An international collaborative study
38. A validation study of the WHO method for cancer pain relief
39. Symptom prevalence and control during cancer patients' last days of life
40. Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unit
41. Patient-related barriers to management of cancer pain
42. Documentation of severe pain, opioid doses, and opioid-related side effects in outpatients with cancer: A retrospective study
43. Validation of World Health Organization Guidelines for cancer pain relief: A 10-year prospective study
44. Unmet analgesic needs in cancer patients